Sickle Cell Disease Conditioning for Bone Marrow Transplant
NCT00968162
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Bone Marrow Transplantation
Sickle Cell Disease
Interventions
DRUG:
fludarabine
Sponsor
Emory University